Science Explorer Back to mapMap
Discussion
Researcher · BGI Group (China) · China

Xin Yi

Xin Yi publishes mostly in Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Plant Molecular Biology Research.

ORCID 0000-0003-4240-7039 OpenAlex
World rank
#312,891
of 7,710,434 ranked researchers
Rank in China
#34,833
of 978,568
Works
193
Citations
8.2k
Citations per work
42.6
h-index
38
i10-index 65Top 8.3% in Molecular Biology
Xin Yi

What does Xin Yi research?

Xin Yi's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (16%), Agricultural and Biological Sciences (7%).

Everything else: 89 works · 45.9% of their workLife Sciences: 74 works · 38.6% of their workBiochemistry, Genetics and Molecular Biology: 61 works · 31.6% of their workMolecular Biology: 31 works · 15.9% of their workCancer Research: 21 works · 10.8% of their workGenetics: 9 works · 4.9% of their workAgricultural and Biological Sciences: 14 works · 7.0% of their workPlant Science: 14 works · 7.0% of their workHealth Sciences: 30 works · 15.5% of their workMedicine: 30 works · 15.5% of their workPulmonary and Respiratory Medicine: 16 works · 8.2% of their workOncology: 14 works · 7.3% of their workTHEIR WORKXin Yi193works
Life Sciences39%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else8945.9%
    1. Biochemistry, Genetics and Molecular Biology6131.6%
    2. Agricultural and Biological Sciences147.0%
    1. Medicine3015.5%
  1. 1Molecular Biology16% of their works
  2. 2Cancer Research11% of their works
  3. 3Pulmonary and Respiratory Medicine8% of their works
  4. 4Oncology7% of their works
  5. 5Plant Science7% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Xin Yi's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, ALK Inhibitors, EGFR Mutations, Epigenetic Regulation, Cancer Stem Cells and Development.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Targeted Therapy612 topics
  2. Cancer Genomics401 topic
  3. Mutational Signatures401 topic
  4. ALK Inhibitors211 topic
  5. EGFR Mutations211 topic
  6. Epigenetic Regulation172 topics
  7. Cancer Stem Cells111 topic
  8. Development111 topic
  9. Microsatellite Instability111 topic
  10. Molecular Characterization111 topic
  11. Plant111 topic
  12. RNA-Seq111 topic
  13. Tumor Metastasis111 topic
  14. sequence alignment111 topic
  15. Copy Number Variation71 topic
  16. Genomic Rearrangements71 topic
  17. Genome Evolution61 topic
  18. Polyploidy61 topic

Where does Xin Yi work?

Xin Yi's main affiliation in the publication record is BGI Group (China), China.

How many publications and citations does Xin Yi have?

OpenAlex counts 193 works and 8,214 citations for Xin Yi, an h-index of 38, ranking #312,891 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Xin Yi

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Xin Yi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.